Literature DB >> 21643483

A geometric characterization of optimal designs for regression models with correlated observations.

Tim Holland-Letz1, Holger Dette, Andrey Pepelyshev.   

Abstract

We consider the problem of optimal design of experiments for random effects models, especially population models, where a small number of correlated observations can be taken on each individual, while the observations corresponding to different individuals are assumed to be uncorrelated. We focus on c-optimal design problems and show that the classical equivalence theorem and the famous geometric characterization of Elfving (1952) from the case of uncorrelated data can be adapted to the problem of selecting optimal sets of observations for the n individual patients. The theory is demonstrated by finding optimal designs for a linear model with correlated observations and a nonlinear random effects population model, which is commonly used in pharmacokinetics.

Entities:  

Year:  2011        PMID: 21643483      PMCID: PMC3106301          DOI: 10.1111/j.1467-9868.2010.00757.x

Source DB:  PubMed          Journal:  J R Stat Soc Series B Stat Methodol        ISSN: 1369-7412            Impact factor:   4.488


  6 in total

1.  Further developments of the Fisher information matrix in nonlinear mixed effects models with evaluation in population pharmacokinetics.

Authors:  Sylvie Retout; France Mentré
Journal:  J Biopharm Stat       Date:  2003-05       Impact factor: 1.051

2.  Population pharmacokinetics of atazanavir in patients with human immunodeficiency virus infection.

Authors:  Sara Colombo; Thierry Buclin; Matthias Cavassini; Laurent A Décosterd; Amalio Telenti; Jérôme Biollaz; Chantal Csajka
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

3.  Analysis of animal pharmacokinetic data: performance of the one point per animal design.

Authors:  E I Ette; A W Kelman; C A Howie; B Whiting
Journal:  J Pharmacokinet Biopharm       Date:  1995-12

Review 4.  Optimal statistical design for toxicokinetic studies.

Authors:  D A Beatty; W W Piegorsch
Journal:  Stat Methods Med Res       Date:  1997-12       Impact factor: 3.021

5.  Estimation of population characteristics of pharmacokinetic parameters from routine clinical data.

Authors:  L B Sheiner; B Rosenberg; V V Marathe
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

6.  Optimum experimental designs for properties of a compartmental model.

Authors:  A C Atkinson; K Chaloner; A M Herzberg; J Juritz
Journal:  Biometrics       Date:  1993-06       Impact factor: 2.571

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.